Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (41-50 of 251) with videos related to

Pageof 26
Sort By:
The New England Journal of Medicine|November 22, 1979
Nephrotoxicity of methyl-CCNUW C Nichols, C G Moertel
Cancer Clinical Trials|January 1, 1979
Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndromeC G Moertel, J A Hanley
Cancer Treatment Reports|November 1, 1979
Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology GroupC G Moertel, P T Lavin
Cancer Treatment Reports|December 1, 1984
Metabolic studies of delta-9-tetrahydrocannabinol in cancer patientsS Frytak, C G Moertel, J Rubin
Cancer Treatment Reports|December 1, 1986
Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndromeC G Moertel, J Rubin, M J O'Connell
Cancer|September 15, 1984
Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancerG Falkson, J M MacIntyre, C G Moertel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferonC G Moertel, J Rubin, L K Kvols
Group Practice|February 11, 1979
A group practice cancer treatment network is bornD Anderson, J N Ingle, C G Moertel
Cancer|January 1, 1991
A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndromeC G Moertel, L K Kvols, J Rubin
Surgery, Gynecology & Obstetrics|October 1, 1973
The malignant carcinoid syndromeZ Davis, C G Moertel, D C McIlrath
Pageof 26

Showing results (41-50 of 251) with videos related to

Sort By:
Pageof 26
The New England Journal of Medicine|November 22, 1979
Nephrotoxicity of methyl-CCNUW C Nichols, C G Moertel
Cancer Clinical Trials|January 1, 1979
Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndromeC G Moertel, J A Hanley
Cancer Treatment Reports|November 1, 1979
Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology GroupC G Moertel, P T Lavin
Cancer Treatment Reports|December 1, 1984
Metabolic studies of delta-9-tetrahydrocannabinol in cancer patientsS Frytak, C G Moertel, J Rubin
Cancer Treatment Reports|December 1, 1986
Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndromeC G Moertel, J Rubin, M J O'Connell
Cancer|September 15, 1984
Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancerG Falkson, J M MacIntyre, C G Moertel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferonC G Moertel, J Rubin, L K Kvols
Group Practice|February 11, 1979
A group practice cancer treatment network is bornD Anderson, J N Ingle, C G Moertel
Cancer|January 1, 1991
A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndromeC G Moertel, L K Kvols, J Rubin
Surgery, Gynecology & Obstetrics|October 1, 1973
The malignant carcinoid syndromeZ Davis, C G Moertel, D C McIlrath
Pageof 26